Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shun Horaguchi"'
Autor:
Feifei Wei, Taku Kouro, Yuko Nakamura, Hiroki Ueda, Susumu Iiizumi, Kyoko Hasegawa, Yuki Asahina, Takeshi Kishida, Soichiro Morinaga, Hidetomo Himuro, Shun Horaguchi, Kayoko Tsuji, Yasunobu Mano, Norihiro Nakamura, Takeshi Kawamura, Tetsuro Sasada
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 23, Iss , Pp 859-869 (2024)
Accurately identifying neoantigens is crucial for developing effective cancer vaccines and improving tumor immunotherapy. Mass spectrometry-based immunopeptidomics has emerged as a promising approach to identifying human leukocyte antigen (HLA) pepti
Externí odkaz:
https://doaj.org/article/3509f12279f4494a86f29ec6284e60a5
Autor:
Shun Horaguchi, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Feifei Wei, Kenta Murotani, Seiichi Udagawa, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami, Terufumi Kato, Tetsuro Kondo, Huihui Xiang, Rika Kasajima, Hidetomo Himuro, Kayoko Tsuji, Yasunobu Mano, Mitsuru Komahashi, Yohei Miyagi, Haruhiro Saito, Koichi Azuma, Shuichiro Uehara, Tetsuro Sasada
Publikováno v:
Biomedicines, Vol 12, Iss 8, p 1831 (2024)
Neutrophil extracellular traps (NETs) released from neutrophils are related to cancer progression. However, the relationship between the therapeutic effects of immune checkpoint inhibitors (ICIs) such as anti-PD-1 and anti-PD-L1 antibodies and plasma
Externí odkaz:
https://doaj.org/article/4b39897048e4485b88664befbd1be51d
Autor:
Yoshiro Nakahara, Taku Kouro, Satoru Motoyama, Masatomo Miura, Kazuma Fujita, Yuka Igarashi, Naoko Higashijima, Norikazu Matsuo, Hidetomo Himuro, Feifei Wei, Shun Horaguchi, Kayoko Tsuji, Yasunobu Mano, Mitsuru Komahashi, Haruhiro Saito, Koichi Azuma, Tetsuro Sasada
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2024)
Introduction: Clinical roles of plasma IL-6 levels have been reported in patients with various cancers, including non-small cell lung cancer (NSCLC), treated with immune checkpoint inhibitors (ICIs). However, the roles of other IL-6 signaling compone
Externí odkaz:
https://doaj.org/article/c99406045248454083cba711ad18ebf5
Autor:
Tetsuro Sasada, Koichi Azuma, Haruhiro Saito, Norikazu Matsuo, Takaaki Tokito, Yohei Miyagi, Terufumi Kato, Tomoyuki Tagami, Kenta Murotani, Feifei Wei, Yoshiro Nakahara, Taku Kouro, Yuka Igarashi, Tetsuro Kondo, Shuji Murakami, Ryo Usui, Hidetomo Himuro, Shun Horaguchi, Kayoko Tsuji, Tatsuma Ban, Tomohiko Tamura
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background Immune checkpoint inhibitor (ICI) therapy has substantially improved the overall survival (OS) in patients with non-small-cell lung cancer (NSCLC); however, its response rate is still modest. In this study, we developed a machine learning-
Externí odkaz:
https://doaj.org/article/2dcd6e25692a40a68ca6114c57cd1999
Autor:
Hidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, Taku Kouro, Naoko Higashijima, Norikazu Matsuo, Shuji Murakami, Feifei Wei, Shun Horaguchi, Kayoko Tsuji, Yasunobu Mano, Haruhiro Saito, Koichi Azuma, Tetsuro Sasada
Publikováno v:
Cancer Immunology, Immunotherapy.
Introduction Immune checkpoint inhibitors (ICI) have significantly improved the prognosis of non-small cell lung cancer (NSCLC). However, only a limited proportion of patients can benefit from this therapy, and clinically useful predictive biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c321377dcd9c3e0e6a11b6b4d157ca35
https://doi.org/10.1007/s00262-023-03464-w
https://doi.org/10.1007/s00262-023-03464-w
Publikováno v:
Journal of Nihon University Medical Association. 79:305-307
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f28bbb3aba5f0433eeb0dde7eb145bd
https://doi.org/10.4264/numa.79.5_305
https://doi.org/10.4264/numa.79.5_305